Cargando…
New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey
In the last decade, systemic therapy for advanced lung cancer has become diverse, complex and personalised. These new therapies (monoclonal antibodies, tyrosine kinase inhibitors (TKIs) and immunotherapy) have a far different toxicity profile compared to chemotherapy. Furthermore, clinical indicatio...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Respiratory Society
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119830/ https://www.ncbi.nlm.nih.gov/pubmed/30186846 http://dx.doi.org/10.1183/23120541.00040-2018 |